PROCEPT BioRobotics Corporation (PRCT) Misses Q4 EPS by 9c

PROCEPT BioRobotics Corporation (NASDAQ: PRCT) reported Q4 EPS of ($0.63), $0.09 worse than the analyst estimate of ($0.54). Revenue for the quarter came in at $23.78 million versus the consensus estimate of $22.91 million.

For earnings history and earnings-related data on PROCEPT BioRobotics Corporation (PRCT) click here.

You May Also Be Interested In

• Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
• Morgan Stanley Starts Adani Enterprises Ltd. (ADE:IN) at Overweight
• Amylyx ALS drug shows no serious adverse events in Phase 1 trial